Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 2
2005 2
2006 1
2009 1
2012 1
2013 1
2014 3
2015 1
2018 6
2019 3
2020 1
2021 4
2022 7
2023 6
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

38 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean maria del campo (10 results)?
Blood-based biomarkers for Alzheimer's disease: towards clinical implementation.
Teunissen CE, Verberk IMW, Thijssen EH, Vermunt L, Hansson O, Zetterberg H, van der Flier WM, Mielke MM, Del Campo M. Teunissen CE, et al. Among authors: del campo m. Lancet Neurol. 2022 Jan;21(1):66-77. doi: 10.1016/S1474-4422(21)00361-6. Epub 2021 Nov 24. Lancet Neurol. 2022. PMID: 34838239 Review.
CSF proteome profiling reveals biomarkers to discriminate dementia with Lewy bodies from Alzheimer´s disease.
Del Campo M, Vermunt L, Peeters CFW, Sieben A, Hok-A-Hin YS, Lleó A, Alcolea D, van Nee M, Engelborghs S, van Alphen JL, Arezoumandan S, Chen-Plotkin A, Irwin DJ, van der Flier WM, Lemstra AW, Teunissen CE. Del Campo M, et al. Nat Commun. 2023 Sep 13;14(1):5635. doi: 10.1038/s41467-023-41122-y. Nat Commun. 2023. PMID: 37704597 Free PMC article.
CSF proteomics in autosomal dominant Alzheimer's disease highlights parallels with sporadic disease.
van der Ende EL, In 't Veld SGJG, Hanskamp I, van der Lee S, Dijkstra JIR, Hok-A-Hin YS, Blujdea ER, van Swieten JC, Irwin DJ, Chen-Plotkin A, Hu WT, Lemstra AW, Pijnenburg YAL, van der Flier WM, Del Campo M, Teunissen CE, Vermunt L. van der Ende EL, et al. Among authors: del campo m. Brain. 2023 Nov 2;146(11):4495-4507. doi: 10.1093/brain/awad213. Brain. 2023. PMID: 37348871 Free PMC article.
CSF proteome profiling across the Alzheimer's disease spectrum reflects the multifactorial nature of the disease and identifies specific biomarker panels.
Del Campo M, Peeters CFW, Johnson ECB, Vermunt L, Hok-A-Hin YS, van Nee M, Chen-Plotkin A, Irwin DJ, Hu WT, Lah JJ, Seyfried NT, Dammer EB, Herradon G, Meeter LH, van Swieten J, Alcolea D, Lleó A, Levey AI, Lemstra AW, Pijnenburg YAL, Visser PJ, Tijms BM, van der Flier WM, Teunissen CE. Del Campo M, et al. Nat Aging. 2022 Nov;2(11):1040-1053. doi: 10.1038/s43587-022-00300-1. Epub 2022 Nov 10. Nat Aging. 2022. PMID: 37118088 Free PMC article.
Role of BRI2 in dementia.
Del Campo M, Teunissen CE. Del Campo M, et al. J Alzheimers Dis. 2014;40(3):481-94. doi: 10.3233/JAD-131364. J Alzheimers Dis. 2014. PMID: 24473189 Review.
Protein disulfide isomerases as CSF biomarkers for the neuronal response to tau pathology.
Wolzak K, Vermunt L, Campo MD, Jorge-Oliva M, van Ziel AM, Li KW, Smit AB, Chen-Ploktkin A, Irwin DJ, Lemstra AW, Pijnenburg Y, van der Flier W, Zetterberg H, Gobom J, Blennow K, Visser PJ, Teunissen CE, Tijms BM, Scheper W. Wolzak K, et al. Among authors: campo md. Alzheimers Dement. 2023 Aug;19(8):3563-3574. doi: 10.1002/alz.12978. Epub 2023 Feb 24. Alzheimers Dement. 2023. PMID: 36825551
Implication of type 4 NADPH oxidase (NOX4) in tauopathy.
Luengo E, Trigo-Alonso P, Fernández-Mendívil C, Nuñez Á, Campo MD, Porrero C, García-Magro N, Negredo P, Senar S, Sánchez-Ramos C, Bernal JA, Rábano A, Hoozemans J, Casas AI, Schmidt HHHW, López MG. Luengo E, et al. Among authors: campo md. Redox Biol. 2022 Feb;49:102210. doi: 10.1016/j.redox.2021.102210. Epub 2021 Dec 10. Redox Biol. 2022. PMID: 34922273 Free PMC article.
38 results